Robert J Vander Zanden Net Worth

The estimated Net Worth of Robert J Vander Zanden is at least $3.58 Tisíc dollars as of 31 May 2017. Robert Zanden owns over 1,000 units of Spherix stock worth over $3,585 and over the last 20 years Robert sold AIKI stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Robert Zanden AIKI stock SEC Form 4 insiders trading

Robert has made over 1 trades of the Spherix stock since 2017, according to the Form 4 filled with the SEC. Most recently Robert bought 1,000 units of AIKI stock worth $1,050 on 31 May 2017.

The largest trade Robert's ever made was buying 1,000 units of Spherix stock on 31 May 2017 worth over $1,050. On average, Robert trades about 40 units every 0 days since 2005. As of 31 May 2017 Robert still owns at least 1,007 units of Spherix stock.

You can see the complete history of Robert Zanden stock trades at the bottom of the page.

What's Robert Zanden's mailing address?

Robert's mailing address filed with the SEC is ONE ROCKEFELLER PLAZA, 11TH FLOOR, , NEW YORK, NY, 10020.

Insiders trading at Spherix

Over the last 21 years, insiders at Spherix have traded over $0 worth of Spherix stock and bought 348,588 units worth $1,675,179 . The most active insiders traders include Anthony Hayes, Soo Yu a Kyle Michael Wool. On average, Spherix executives and independent directors trade stock every 85 days with the average trade being worth of $32,656. The most recent stock trade was executed by Kyle Michael Yu Soo Wool on 19 December 2022, trading 5,000 units of AIKI stock currently worth $17,950.

What does Spherix do?

Spherix, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.

Complete history of Robert Zanden stock trades at Spherix

Spherix executives and stock owners

Spherix executives and other stock owners filed with the SEC include:

• Anthony C. Hayes Esq.,
  CEO, Principal Financial Officer, Principal Accounting Officer & Director
• Darrell Dotson,
  VP of Drug Devel. & Gen. Counsel
• Frank Reiner,
  Interim CFO
• Eric Weisblum,
  Director
• Tim S Ledwick,
  Director
• Alexander I. Poltorak,
  
• Robert J Vander Zanden,
  Director
• Jeffrey Ballabon,
  Director
• Howard E Goldberg,
  Director
• Anthony Hayes,
  CEO
• Claire L Kruger,
  CEO
• Gilbert V Levin,
  CEO
• Robert A Lodder,
  President
• Richard Coleman Levin,
  Executive VP, CFO & Treasurer
• Thomas G Moore,
  Director
• M Karen Levin,
  VP, Corp. Comm.
• Robert Clayton,
  CFO & Treasurer
• Anne S Macleod,
  Director
• Thomas Peter,
  Director
• George C Creel,
  Director
• Thomas W Gantt,
  CEO/President
• Douglas T Brown,
  Director
• Melissaratos Aristides,
  Director
• Roger A Downs,
  VP, InfoSpherix Operations
• Paul Jr Cox,
  Director
• Jeffrey T Lowe,
  VP, Corp. Communications
• Steven M Wade,
  VP, Info. Tech., InfoSpherix
• Lionel V Baldwin,
  Director
• Carol Y Sanchez,
  Director
• Gregory James Blattner,
  Director
• Harvey J Kesner,
  Director
• Edward M Karr,
  
• Robert Frederick Dudley,
  Director
• Paul Le Mire,
  Director
• Kyle Michael Yu Soo Wool,
  
• Soo Yu,
  Director
• Kyle Michael Wool,
  Director